Valuation dashboard for RadNet, Inc. (RDNT) with P/E N/A, P/B 4.96, EV/EBITDA 20.77 and dividend yield 0.00%. DCF, Graham Number, EPS growth, peer multiples and dividend discount models plus sector comparison against other Healthcare companies.
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures.
Analysis Summary
RadNet, Inc. reported revenue of $2.04B in the most recent fiscal year, growing at a 5-year CAGR of 13.7%.
Trailing-twelve-month margins: gross margin 9.7%, operating margin 4.0%, net margin -0.9%.
At the current price of $70.57, RDNT has negative trailing earnings (P/E not meaningful) and an ROE of -1.95%. Market capitalisation stands at $5.5B.
Balance sheet quality for RDNT: current ratio of 1.8. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 4.96 |
| EV / EBITDA | 20.77 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-31.81 |
| vs Current Price | -145.1% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| RDNT | RadNet, Inc. | $5.5B | 4.96 | -2.0% | |
| BTSG | BrightSpring Health Services, Inc. Common Stock | $11.8B | 43.36 | 6.24 | 15.2% |
| KRYS | Krystal Biotech, Inc. | $9.6B | 38.97 | 7.00 | 16.8% |
| BRKR | Bruker Corporation | $9.7B | 4.01 | -2.9% | |
| MMSI | Merit Medical Systems, Inc. | $5.1B | 40.62 | 3.29 | 8.1% |
| IRTC | iRhythm Technologies, Inc. | $3.6B | 19.31 | -9.0% | |
| BLCO | Bausch + Lomb Corporation | $6.1B | 0.96 | -2.7% | |
| CHE | Chemed Corporation | $6.6B | 25.48 | 8.20 | 29.5% |
Price
| Price | $70.57 |
| Market Cap | $5.5B |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -1.95% |
| Return on Invested Capital | 1.38% |
| Return on Assets | -0.50% |
| Gross Margin | 9.70% |
| Operating Margin | 4.00% |
| Net Margin | -0.93% |
Related companies: BLCO · BRKR · BTSG · CHE · IRTC · KRYS · MMSI
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of RDNT: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks